Shopping Cart
- Remove All
- Your shopping cart is currently empty
GFB-12811 is an orally active, selective, and potent CDK5 inhibitor, used in the study of autosomal dominant polycystic kidney disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $329 | In Stock | |
5 mg | $787 | In Stock | |
10 mg | $1,230 | In Stock | |
25 mg | $2,530 | In Stock | |
50 mg | $3,390 | In Stock | |
1 mL x 10 mM (in DMSO) | $883 | In Stock |
Description | GFB-12811 is an orally active, selective, and potent CDK5 inhibitor, used in the study of autosomal dominant polycystic kidney disease. |
Targets&IC50 | CDK5:2.3 nM |
In vitro | GFB-12811 is a highly selective CDK5 inhibitor with IC50=2.3 nM. [1] |
Alias | GFB12811 |
Molecular Weight | 449.44 |
Formula | C22H23F4N5O |
Cas No. | 2775311-17-4 |
Smiles | [C@](C)(O)(C1=NC2=C(C=C1)C=NC(NC=3C=C(C(F)(F)F)N=CC3F)=C2)C4CCN(C)CC4 |
Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.